Targeted therapy is used when standard chemotherapy has not been effective. This therapy is not widely available and can only be ordered through specialty pharmacies.
Liver cancer patients who cannot have liver surgery should consider this therapy.
Pills works to target specific cancer cells to inhibit their spreading. As this treatment is designed to damage only the harmful cells, healthy cells are not affected.
This therapy typically involves taking two pills twice per day, for as long as a doctor advises.
This therapy has been shown to slow the growth of advanced stage liver cancer. On average, it is estimated that patients receiving this treatment live 44% longer, or 3 months longer, than patients who do not utilize this treatment.
Side effects of targeted therapy include fatigue, rash, appetite, diarrhea, irritated skin, blisters on palms or soles, high blood pressure, and fertility complications.
• women who are pregnant or nursing
• men or women who wish to conceive, or who are not taking the proper precautions to prevent pregnancy
• patients with poor liver function or squamous cell lung cancer
Products used in targeted therapy include: sorafenib (Nexavar®) by Onyx/Bayer, anti-angiogenic drugs and kinase inhibitors.
Insurance sometimes covers this treatment, at least in part. Contact your healthcare provider for information regarding your exact policy. Costs for targeted therapy without insurance are approximately $2,500-8,000 per month, depending on duration, geographical location, and individual needs.
Copyright © 2025 · All Rights Reserved · LiverDirectory.com
America’s Most Comprehensive Liver Health Network
Connecting Patients with Doctors, Support Groups, and Pharmacies Nationwide